Anavo Therapeutics
Human phosphatase biology company
Anavo Therapeutics has raised €8.5M across 1 funding round from 5 investors, most recently a Seed round in May 2023. Based in Leiden, Netherlands; active in Healthtech. Data as of 4 Nov 2026.
Leiden, Netherlandswww.anavotx.com ↗
Total raised
€8.5M
€8,500,000
Funding rounds
1
Investors
5
distinct backers
Active since
2023-05
latest 2023-05
Funding by year
EUR raised per yearAnavo Therapeutics — funding by year — interactive chart.
Data table
| Anavo Therapeutics — funding by year | |
|---|---|
| 2023 | €8.5M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Seed
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-05-02 | Seed | €8.5M | Bioqube Ventures,INKEF Capital,M Ventures,MRL Ventures Fund,Taiho Ventures | View deal → |
Related news
Similar companies
same sector, similar size- Thirona€7.5MNetherlands · Healthtech
- DEBx Medical€10MNetherlands · Healthtech
- Nowatch€8.4MNetherlands · Healthtech
- Founda Health€12MNetherlands · Healthtech
- CimCure€5.0MNetherlands · Healthtech
- Amber Implants€8.8MNetherlands · Healthtech
Global coverage: FundingData